Related Experiment Videos
The carcinoembryonic antigen (CEA) modulates effector-target cell interaction by binding to activated lymphocytes
1Institute of Immunobiology, University of Freiburg, Germany.
International Journal of Cancer
|November 15, 1996
Summary
The density of carcinoembryonic antigen (CEA) on tumor cells affects their protection against cytotoxic lymphocytes. Membrane-bound CEA binds to effector cells, suggesting tumor cells regulate immune evasion by controlling CEA levels.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Carcinoembryonic antigen (CEA) is implicated in modulating tumor cell susceptibility to cytotoxic lymphocytes.
- The precise mechanism by which CEA influences immune evasion remains incompletely understood.
Purpose of the Study:
- To investigate the role of CEA density on tumor cell surfaces in immune evasion.
- To elucidate the binding interactions between CEA and lymphokine-activated killer (LAK) cells.
Main Methods:
- Co-culture of CEA-expressing tumor cells with LAK cells.
- FACScan analysis to detect CEA on lymphocytes.
- Assessment of CEA binding to LAK cells under varying conditions.
Main Results:
- Membrane-bound CEA, not soluble CEA, confers protection to tumor cells.
- Intercellular contact is necessary for CEA binding to LAK cells.
- CEA is released from tumor cells after binding to LAK cells, indicating a dynamic interaction.
Conclusions:
- Tumor cell surface CEA density is a critical factor in modulating immune cell interactions.
- CEA release following LAK cell binding suggests a mechanism for immune evasion.
- Tumor cells may regulate effector cell adhesion by controlling CEA turnover on their membrane.